Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1992 Dec 1;89(23):11391–11395. doi: 10.1073/pnas.89.23.11391

The role of endogenous atrial natriuretic peptide in resting and stress-induced release of corticotropin, prolactin, growth hormone, and thyroid-stimulating hormone.

C R Franci 1, J A Anselmo-Franci 1, S M McCann 1
PMCID: PMC50556  PMID: 1333608

Abstract

Our previous studies have shown that stimulation of the anteroventral third ventricle region increases atrial natriuretic peptide (ANP) release, whereas lesions of the anteroventral third ventricle or median eminence block the release of ANP from blood volume expansion, suggesting a critical central nervous system participation in this response. ANP is also produced within neurons that have cell bodies in the rostral hypothalamus and axons that extend to the median eminence and neural lobe. In addition to its natriuretic effect, the peptide can inhibit the release of corticotropin (ACTH) and prolactin, anterior pituitary hormones that are released during stress. To determine the physiologic significance of ANP in the control of basal and stress-induced release of anterior pituitary hormones, highly specific antiserum against the peptide (AB-ANP) was microinjected into the third cerebral ventricle of conscious freely moving male rats to immunoneutralize hypothalamic ANP. In the initial experiment, the antiserum or control normal rabbit serum (NRS) was injected into the third cerebral ventricle to determine the effect of the antiserum on basal release of pituitary hormones. The antiserum had no effect on the concentrations of plasma ACTH, prolactin, or thyroid-stimulating hormone for 3 hr after the injection; however, plasma growth hormone concentration, although unchanged for 2 hr, was markedly elevated at 3 hr. These results indicate that although ANP appears to have no effect on the basal release of the other hormones, it has a physiologically significant inhibitory effect on growth hormone release. The delay of the effect is probably related to the time required for the antiserum to diffuse to the site of action of the peptide, presumably at some distance from the ventricle. Since this effect was demonstrable only after 3 hr, in the stress experiment, the antiserum or NRS was microinjected into the third ventricle 3 hr prior to application of ether stress. The rapid elevation of plasma ACTH in NRS-injected rats was markedly augmented by AB-ANP. Ether also induced a rapid increase in plasma prolactin in the NRS-injected animals, as expected. Contrary to the ACTH response, the maximal increase in plasma prolactin after ether was attenuated in animals preinjected with AB-ANP. In the NRS-injected animals, there was a significant decline in plasma growth hormone after the application of ether that was significantly accentuated by AB-ANP, but this was probably the result of the higher initial levels of plasma growth hormone in the ANP-AB group followed by its disappearance with a half-time similar to that of the NRS-injected group. The decline in plasma thyroid-stimulating hormone after ether stress was unaltered in the animals injected with AB-ANP. The results of these immunoneutralization studies suggest that endogenous ANP does not play a role in thyroid-stimulating hormone release. On the other hand, the endogenous peptide appears to have a physiologically significant inhibitory role in suppressing ACTH release during stress, mediated at least partly by suppression of vasopressin release. Endogenous ANP has a pathophysiologic role in augmenting the prolactin release in stress either by inhibiting release of prolactin-inhibiting factors or, alternatively, by enhancing release of prolactin-releasing factors. Endogenous ANP appears to inhibit resting, without altering stress-induced inhibition of growth hormone release by stimulating somatostatin release and/or inhibiting growth hormone-releasing hormone release or by both actions.

Full text

PDF
11391

Images in this article

11393Image
on p.11393
11393Image
on p.11393
11394Image
on p.11394
11394Image
on p.11394

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aguila M. C., Pickle R. L., Yu W. H., McCann S. M. Roles of somatostatin and growth hormone-releasing factor in ether stress inhibition of growth hormone release. Neuroendocrinology. 1991 Nov;54(5):515–520. doi: 10.1159/000125946. [DOI] [PubMed] [Google Scholar]
  2. Antunes-Rodrigues J., McCann S. M., Rogers L. C., Samson W. K. Atrial natriuretic factor inhibits dehydration- and angiotensin II-induced water intake in the conscious, unrestrained rat. Proc Natl Acad Sci U S A. 1985 Dec;82(24):8720–8723. doi: 10.1073/pnas.82.24.8720. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Antunes-Rodrigues J., McCann S. M., Samson W. K. Central administration of atrial natriuretic factor inhibits saline preference in the rat. Endocrinology. 1986 Apr;118(4):1726–1728. doi: 10.1210/endo-118-4-1726. [DOI] [PubMed] [Google Scholar]
  4. Antunes-Rodrigues J., McCann S. M. Water, sodium chloride, and food intake induced by injections of cholinergic and adrenergic drugs into the third ventricle of the rat brain. Proc Soc Exp Biol Med. 1970 Apr;133(4):1464–1470. doi: 10.3181/00379727-133-34713. [DOI] [PubMed] [Google Scholar]
  5. Franci C. R., Anselmo-Franci J. A., McCann S. M. Opposite effects of central immunoneutralization of angiotensin II or atrial natriuretic peptide on luteinizing hormone release in ovariectomized rats. Neuroendocrinology. 1990 Jun;51(6):683–687. doi: 10.1159/000125410. [DOI] [PubMed] [Google Scholar]
  6. Franci C. R., Kozlowski G. P., McCann S. M. Water intake in rats subjected to hypothalamic immunoneutralization of angiotensin II, atrial natriuretic peptide, vasopressin, or oxytocin. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2952–2956. doi: 10.1073/pnas.86.8.2952. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Goodfriend T. L., Elliott M. E., Atlas S. A. Actions of synthetic atrial natriuretic factor on bovine adrenal glomerulosa. Life Sci. 1984 Oct 15;35(16):1675–1682. doi: 10.1016/0024-3205(84)90179-6. [DOI] [PubMed] [Google Scholar]
  8. Harms P. G., Ojeda S. R. A rapid and simple procedure for chronic cannulation of the rat jugular vein. J Appl Physiol. 1974 Mar;36(3):391–392. doi: 10.1152/jappl.1974.36.3.391. [DOI] [PubMed] [Google Scholar]
  9. Jacobowitz D. M., Skofitsch G., Keiser H. R., Eskay R. L., Zamir N. Evidence for the existence of atrial natriuretic factor-containing neurons in the rat brain. Neuroendocrinology. 1985 Jan;40(1):92–94. doi: 10.1159/000124058. [DOI] [PubMed] [Google Scholar]
  10. Masotto C., Negro-Vilar A. Inhibition of spontaneous or angiotensin II-stimulated water intake by atrial natriuretic factor. Brain Res Bull. 1985 Nov;15(5):523–526. doi: 10.1016/0361-9230(85)90044-9. [DOI] [PubMed] [Google Scholar]
  11. McCann S. M., Rettori V., Milenkovic L., Jurcovicová J., González M. C. Role of monokines in control of anterior pituitary hormone release. Adv Exp Med Biol. 1990;274:315–329. doi: 10.1007/978-1-4684-5799-5_20. [DOI] [PubMed] [Google Scholar]
  12. Murakami Y., Kato Y., Tojo K., Inoue T., Yanaihara N., Imura H. Stimulation of growth hormone secretion by central administration of atrial natriuretic polypeptide in the rat. Endocrinology. 1988 May;122(5):2103–2108. doi: 10.1210/endo-122-5-2103. [DOI] [PubMed] [Google Scholar]
  13. Nakamaru M., Takayanagi R., Inagami T. Effect of atrial natriuretic factor on central angiotensin II-induced responses in rats. Peptides. 1986 Mar-Apr;7(2):373–375. doi: 10.1016/0196-9781(86)90239-1. [DOI] [PubMed] [Google Scholar]
  14. Nicholson W. E., Davis D. R., Sherrell B. J., Orth D. N. Rapid radioimmunoassay for corticotropin in unextracted human plasma. Clin Chem. 1984 Feb;30(2):259–265. [PubMed] [Google Scholar]
  15. Ono N., Bedran de Castro J. C., McCann S. M. Ultrashort-loop positive feedback of corticotropin (ACTH)-releasing factor to enhance ACTH release in stress. Proc Natl Acad Sci U S A. 1985 May;82(10):3528–3531. doi: 10.1073/pnas.82.10.3528. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ono N., Lumpkin M. D., Samson W. K., McDonald J. K., McCann S. M. Intrahypothalamic action of corticotrophin-releasing factor (CRF) to inhibit growth hormone and LH release in the rat. Life Sci. 1984 Sep 3;35(10):1117–1123. doi: 10.1016/0024-3205(84)90077-8. [DOI] [PubMed] [Google Scholar]
  17. Ono N., Samson W. K., McDonald J. K., Lumpkin M. D., Bedran de Castro J. C., McCann S. M. Effects of intravenous and intraventricular injection of antisera directed against corticotropin-releasing factor on the secretion of anterior pituitary hormones. Proc Natl Acad Sci U S A. 1985 Nov;82(22):7787–7790. doi: 10.1073/pnas.82.22.7787. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ottlecz A., Snyder G. D., McCann S. M. Regulatory role of galanin in control of hypothalamic-anterior pituitary function. Proc Natl Acad Sci U S A. 1988 Dec;85(24):9861–9865. doi: 10.1073/pnas.85.24.9861. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Samson W. K., Bianchi R. Further evidence for a hypothalamic site of action of atrial natriuretic factor: inhibition of prolactin secretion in the conscious rat. Can J Physiol Pharmacol. 1988 Mar;66(3):301–305. doi: 10.1139/y88-051. [DOI] [PubMed] [Google Scholar]
  20. Samson W. K. Dehydration-induced alterations in rat brain vasopressin and atrial natriuretic factor immunoreactivity. Endocrinology. 1985 Sep;117(3):1279–1281. doi: 10.1210/endo-117-3-1279. [DOI] [PubMed] [Google Scholar]
  21. Samson W. K., Lumpkin M. D., McCann S. M. Evidence for a physiological role for oxytocin in the control of prolactin secretion. Endocrinology. 1986 Aug;119(2):554–560. doi: 10.1210/endo-119-2-554. [DOI] [PubMed] [Google Scholar]
  22. Shibasaki T., Naruse M., Yamauchi N., Masuda A., Imaki T., Naruse K., Demura H., Ling N., Inagami T., Shizume K. Rat atrial natriuretic factor suppresses proopiomelanocortin-derived peptides secretion from both anterior and intermediate lobe cells and growth hormone release from anterior lobe cells of rat pituitary in vitro. Biochem Biophys Res Commun. 1986 Mar 28;135(3):1035–1041. doi: 10.1016/0006-291x(86)91032-6. [DOI] [PubMed] [Google Scholar]
  23. Stier C. T., Jr, Cowden E. A., Friesen H. G., Allison M. E. Prolactin and the rat kidney: a clearance and micropuncture study. Endocrinology. 1984 Jul;115(1):362–367. doi: 10.1210/endo-115-1-362. [DOI] [PubMed] [Google Scholar]
  24. de Bold A. J. Atrial natriuretic factor of the rat heart. Studies on isolation and properties. Proc Soc Exp Biol Med. 1982 Jun;170(2):133–138. doi: 10.3181/00379727-170-41408. [DOI] [PubMed] [Google Scholar]
  25. de Bold A. J., Borenstein H. B., Veress A. T., Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci. 1981 Jan 5;28(1):89–94. doi: 10.1016/0024-3205(81)90370-2. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES